logo-full arrow-left arrow-right magnify story members projects twitter facebook youtube download

By Laurie Edmiston, CATIE Earlier this year, I witnessed a profound historic moment at the International AIDS Conference in Amsterdam. Dr. Alison Rodger, a leading HIV researcher in the United Kingdom, presented the final results from a study of couples with one HIV-positive and one HIV-negative partner. After eight years of the study, she reported, there were zero cases of HIV transmission from one partner to the other – thanks to the prevention benefits of modern HIV medications. The evidence has been mounting for years. Several large clinical trials have confirmed that HIV treatment can suppress the virus so successfully that sexual transmission doesn’t occur. Three-quarters of Canadians diagnosed with … Lire la suite 


 

New Research Priorities from the US National Institutes of Health (NIH) Restricts Prevention Options By Marc-André LeBlanc, Founding member of IRMA

International Rectal Microbicide Advocates (IRMA) and our many partners and allies believe we need an array of HIV prevention options. There has been enormous progress in the field of HIV prevention research in recent years. The remarkably high efficacy of antiretroviral drugs (ARVs) for prevention has been demonstrated, both for oral pre-exposure prophylaxis ( PrEP, now approved and subsidized in several countries ) and through treatment leading to viral suppression or “undetectability” ( U=U, Undetectable = Untransmittable ).

Microbicide—products that could be used vaginally or rectally to reduce a … Lire la suite 


 

By Jes Hovanes, Communications and Social Media Officer, CIHR Canadian HIV Trials Network There is a line in Tony Kushner’s 1991 play Angels in America where, in the early days of the HIV epidemic, the character Belize, a nurse working in the AIDS ward in New York, warns Roy Cohn, who is dying of AIDS, to “watch out for the double-blind. They’ll want you to sign something that says they can give you M&M’s instead of the real drug. You’ll die, but they’ll get the kind of statistics they can publish in The New England Journal of Medicine…” Thankfully, this portrayed gap between the interests of medical researchers and the … Lire la suite